A month on, 21 states and UTs have not administered a single shot of the vaccine
The ratings agency does not expect Indian pharmaceutical companies to sustain the healthy operating margins reported during 3Q FY21 and 9M FY21
Drug firmAstraZeneca Pharma India on Monday reported a 21 per cent decline in net profit at Rs 21.05 crore for the quarter ended in December
Online travel portals and airlines say the demand from companies is being led by essential services sectors like pharmaceutical, oil and gas, and power
Mumbai-based pulmonologist Dr Agam Vora said in the first few months of the pandemic, the line of treatment was not established
With API supply, especially from China, facing some constraints because of lockdowns in several countries, demand from global clients had shot up for Indian players
US formulations business dips 4% with revenues at Rs 1,603 cr, Q3 sees Zydus file 10 additional ANDAs with US FDA, taking total filings to 410
As for Bharat Biotech's chimpanzee flu virus (adenovirus) based intra-nasal vaccine candidate, the SEC recommended grant of permission for phase I trials
As for Bharat Biotech's chimpanzee flu virus (adenovirus) based intra-nasal vaccine candidate, the SEC recommended grant of permission for phase I trials
Regeneron's antibody cocktail garnered $145.5 million in sales for the fourth quarter. While, the consensus Wall Street estimate was $173 million, according to Guggenheim analyst Yatin Suneja.
Pfizer has not conducted any bridge trial on Indian population for its mRNA vaccine
Frazier, 66, will remain with the drugmaker as executive chairman for a transition period to be determined by the board.
The trial has assessed its efficacy during a period with high transmission and with a new UK strain of the virus
World cases cross 100 mn, Italian politics and Dutch protests add to Europe's Covid woes, Japan wants domestic trials before vaccine roll-out and other pandemic-related news across the globe
To raise manufacturing capacity by 30% over next 2 months from present 2.4 mn doses
NeuroRx and Relief Therapeutics have partnered to develop a drug called RLF-100 that has anti-inflammatory and anti-cytokine activity properties.
Top European biz group with representation from top firms to approach govt for guidelines
Around November, IIL had indicated that it was open to discussions with the US major.
Three flights carrying COVID-19 vaccines from Pune and Hyderabad landed at the Delhi airport on Wednesday, its spokesperson said.
These sectors will face another tough year after coronavirus pandemic, the first challenge being vaccination of India's 1.3 billion people. Devangshu Datta explains the opportunities and threats